{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1381699994021844757.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Hagop Akiskal"}],"foaf:familyName":[{"@value":"Akiskal"}],"foaf:givenName":[{"@value":"Hagop"}]}],"career":[{"institution":{"notation":[{"@value":"From the Bipolar Disorders Program, Clinical Institute of Neuroscience, Hospital Clinic Barcelona, IDIBAPS (Institute of Biomedical Research August Pi i Sunyer), CIBERSAM (Center for Biomedical Research Network on Mental Health), University of Barcelona, Barcelona, Spain; Mood Disorders Centre, Department of Psychiatry, University of British Columbia, Vancouver; Department of Psychiatry, Harvard Medical School, Boston; Department of Psychiatry, University Medical Center Groningen, University of Groningen..."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1361699994021844736","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1176/appi.ajp.2013.13020185"},{"@type":"URI","@value":"http://psychiatryonline.org/doi/10.1176/appi.ajp.2013.13020185"}],"notation":[{"@value":"The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1176/appi.ajp.2013.13020185_2uh7pBuCayduWuKqdJk8ATzkjnc"}]}